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Patients talcin\a low-dote aspirin dail):. to protect aga~st strokes and heart attack get an added bonus-a 
reduction in their risk of developing cancer, 
pa~ularly colorectal cancer. 
Thi~'5sociation has fueled research to 
determine t'he molecular pathways through 
which aspirin prevents cancer development, 
a~ to associate pharmaceutical 
sciences professor Jayarama Guna·e. "This 
observation e t e attention of 
p · · ns, scientists and the public alike-
evt\-ybody is interested:' 
More than 1.6 million Americans are 
diagnosed with cancer and nearly 600,000 of 
those patients die every year, according to the 
Americtm Ganeer Society. 
"We know \ow aspirin decreases 
inflammation and heart attacks, but no one 
know)~ly how it prevents cancer:' Gunaje 
said. He began unrateling the molecular 
mechanisms throug which aspjrin prevents 
cancer in 2006 when he was at'l'exas Tech 
University. He came to SDSU in 2011. 
While at Texas Tech, Gunaje's research was 
funded by National Institutes of Health 
grants. His research at South Dakota State has 
been supported by the Translational Cancer 
Research Center and the Scholarly Faculty 
Excellence Fund. Two doctoral students, 
Guoqiang Ai and Rakesh Dachineni, have 
worked on these projects. 
Only two drugs- tamoxifen and 
raloxifene-have been developed to prevent 
cancer recurrence, with both targeting breast 
cancer. What Gunaje and other scientists 
discover may help identify and develop new 
cancer-preventing drugs/compounds. 
Moving toward cancer 
In the 1980s, an Australian study reported 
that people talcing aspirin daily were 40 
percent less likely to develop colorectal cancer 
than those who did not adhere to this 
regimen, Gunaje recalled. 
More recently, a 2010 study in the United 
Kingdom analyzed data from 51 trials in 
which patients took a low-dose aspirin daily 
for five years and found 37 percent fewer 
deaths from cancer. However, Gunaje noted, 
these studies were not designed to directly 
assess the molecular mechanisms through 
which aspirin prevents cancer. 
Evidence about aspirin's impact on 
colorectal cancer, in particular, led to the U. S. 
Preventive Service Task Force recommending 
the use of low-dose aspirin as a means of 
preventing cardiovascular disease-and 
colorectal cancer-for some adults, ranging 
from 50 to 69 years old. This is the first time 
that a major American medical organization 
has suggested aspirin as a means of 
preventing colorectal cancer in average-risk 
adults, according to a February 2016 New 
Hampshire Comprehensive Cancer 
Collaboration article. 
Blocking enzyme, proteins 
Essentially, aspirin inactivates enzymes 
n as cyclooxygenases, or COX, through 
a process known as acetylation. That then 
decreases the synthesis of prostaglandins, 
which are responsible for pain, inflammation 
and fever, GunaJe 1:xpl,1inc<l. This mechanism 
also prevents the formation of blood clots by 
permanently inactivating platelets. 
Given this information, Gunaje and his 
team explored whether aspirin inhibits the 
functions of other proteins. For instance, 
protein p53 acts as a tumor suppressor. An 
estimated 50 percent of all cancers have 
mutated p53, meaning the protein is 
inactivated. "That favors cancer cell growth:' 
he pointed out. 
Using colorectal cancer cells, Gunaje and 
his team found that "aspirin acetylates p53 
and reactivates the mutant p53, thus restoring 
its function as a tumor suppressor. This is a 
significant finding because lots of companies 
are interested in reactivating p53 as a strategy 
to treat cancer:' 
Exploring binding, inhibiting powers 
Aspirin is made of two components, 
acetyl and salicylic acid groups. "Salicylic acid 
is a hormone in plants that helps prevent 
infection:' Gunaje said, noting that it was 
originally extracted from willow tree bark. It 
is also present in apples, kiwi, cranberries, 
strawberries and other berries. 
Aspirin is absorbed intact in the 
gastrointestinal tract and later broken down 
into acetate and salicylate ions in the liver and 
blood plasma, he said. "We think aspirin's 
ability to decrease cancer can be attributed to 
the intact aspirin and salicylic acid or its 
metabolites, which are formed in the liver:' 
To investigate salicylic acid's possible 
cancer-fighting targets, Gunaje looked at two 
proteins that work together to regulate cell 
division--cyclin-dependent protein kinase 2, 
or CDK2, which binds to cyclin A2 in body 
cells. This interaction increases the activity of 
CDK2, thus signaling the cell to proceed to 
the next stage of cell division. 
Other researchers found that both CDK2 
and cyclin A2 are either deregulated or 
upregulated in breast, liver and lung cancers. 
Therefore, inhibiting CDK2 has been 
identified as a possible means of treating 
and/or preventing cancer. 
Gunaje and his team confirmed that 
aspirin and salicylic acid decreased cyclin A2 
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and CDK2 levels in lung, colon, prostate, 
ovary and skin cancer cells. They then tested 
the hypothesis that salicylic acid binds to 
CDK2, thus interrupting the cyclin A2/CDK2 
interaction and therefore halting cancer cell 
reproduction. 
His recent results showed that several 
salicylic-acid derivatives bind to CDK2 
enzymes and significantly inhibit the enzyme 
function, providing a basis for the 
development of new CDK inhibitors. "We are 
excited about this discovery:' Gunaje said. 
Identifying and developing these new anti-
cancer drugs will have a significant impact on 
preventing cancer and improving human 
health. 
Above: Gel electrophoresis is used to analyze how salicylic 
acid and its metabolites affect proteins that regulate cell 
division. 
Below: Doctoral student Rakesh Dachineni and associate 
professor Jayarama Gunaje examine data on the Inhibitory 
effect of salicylic acid and its derivatives on cyclin-dependent 
kinase activity. 
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Problem-solving, cornerstone 
of SDSU research 
American philosopher, psychologist and educational reformer 
John Dewey said, ·a problem well put is half solved." Fluid flow model evaluates clotting risk in 
Discovering solutions is the cornerstone upon which this land-
grant institution's research mission is based. This publication features 
the work of scientists and engineers who seek to improve human 
health, treat and prevent diseases, and protect the nation's food 
supply. NEW STENT 
As associate professor Stephen Gent puts it, "We are trying to 
answer really tough questions while also being responsible as we 
work through them." The data from his computational fluid dynamics 
models help Sanford Health vascular surgeon Patrick Kelly and his 
product development team assess the quality of blood flow through 
new stent graft designs. Gent is our first mechanical engineering 
faculty member to do this type of research. 
GRAFT DESIGN 
Three stories highlight accomplishments made through South 
Dakota's BioSystems Networks and Translational Research (BioSNTR), 
a collaborative center established in 2013 through a South Dakota 
Experimental Program to Stimulate Competitive Research National 
Science Foundation RII Track 1 award designed to build infrastructure 
and support research on human, animal and plant diseases. 
Through BioSNTR, researchers from South Dakota State and the 
University of South Dakota are investigating how antibodies recognize W:ether patients with mechanical heart valves 
their targets, activate immune cells and clear influenza from the body. nd stents must take blood thinners depends on 
BioSNTR scientists have also been instrumental in establishing a ow effectively blood flows through these 
genome-sequencing laboratory and building faculty expertise in implantable medical devices. Researchers have modeled 
bioinformatics that helps make sense of these large datasets. the flow of blood through left ventricular assist devices 
To help individuals at risk for developing cardiovascular disease 
and diabetes, associate professor Moul Dey led the first study to and mechanical heart valves to estimate clotting risk, but 
examine the prebiotic impact of a nondigestible wheat fiber for this type of work has not been done on stent grafts-until 
individuals with metabolic syndrome. In addition, associate now. 
pharmaceutical sciences professor Jayarama Gunaje is identifying the Associate mechanical engineering professor Stephen 
molecular mechanism through which a daily dose of aspirin reduces a Gent collaborated with Sanford Health vascular surgeon 
person's risk of developing cancer, particularly colorectal cancer. Pat Kelly and biomedical engineer Tyler Remund to 
Working with Avera Health, Mary Minton and Mary Isaacson evaluate whether a new branching stent design might 
surveyed nurses about their comfort levels and techniques used to increase the risk of blood clots. 
guide terminally ill patients through palliative and end-of-life care "An orderly straight-through flow is optimal,"said 
planning. They hope to integrate those strategies and communication Gent, who has done computational fluid dynamic techniques into the nursing curriculum and professional workshops. 
Stephen Gent 
incision from the shoulder blades to the groin. The 
flexible, branching stent grafts that Kelly designs may 
provide a less invasive alternative. 
Of particular concern, was the flow through a section 
of the branching stent graft where the blood from the 
main channel, or aorta, branches to the celiac artery, 
superior mesenteric artery and renal arteries which 
transport blood to vital organs, according to Remund. 
"The FDA want:. to make sure that you've assessed the 
risk-benefit ratio and addressed as many risks as possible." 
The researchers incorporated aspects of a flow model 
designed to assess the likelihood of clots forming in 
mechanical heart valves into their stent graft model. Then 
they compared the results with those from two mechanical 
heart valves and an idealized aorta. 
And finally, researchers at the South Dakota Animal Disease modeling of stent grafts for the Sanford team since 2014. 
Research and Diagnostic Lab are assessing the pathways through This work builds on a previous model that provided Evaluating risk of clotting 
which foreign animal diseases, specifically swine viruses, might reach supporting evidence for well-developed blood flow "As we expected, Kelly's design performs an order of 
the United States. through a similarly designed stent, which is now part of a magnitude lower than was reported for the mechanical 
As Dewey pointed out, the enthusiasm and dedication with which Food and Drug Administration-approved investigational heart valves, both of which are FDA-approved for IDE 
our scientists and engineers tackle these problems set them on the device exemption, or IDE, clinical trial. clinical trials;' said Gent, who is the first mechanical 
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Journal of Vascular Surgery. Both projects were made research. Furthermore, the blood flow through the stent 
possible through grants from Sanford Research. graft was comparable to that of the idealized aorta. 
Providing options for patients 
Only a small number of patients-two per 100,000 a 
year-are diagnosed with thoracoabdominal aneurysms, 
according to Kelly. However, most of those patients would 
not survive traditional open surgery, which involves an 
"Vascular surgeons want the flow to be laminar, so it 
does not induce turbulence," Gent said. When the blood 
flows becomes more disturbed, this induces more shear 
stress on the platelets in the blood. Over time this shear 
stress, also known as shear accumulation, can damage or 
activate platelets that can cause them to form clots. These 
This proposed prototype for a stent graft designed by Sanford Health 
vascular surgeon Pat Kelly makes use of a diaphragm where the flow is 
diverted from the aorta to each of the branch vessels. Computational fluid 
dynamics modeling to assess the risk of blood clots forming showed blood 
flow through this stent graft is comparable to that of an idealized aorta. 
clots can break off and go downstream where they 
can easily block blood flow to vital organs, such as 
the stomach and liver. This is known as 
thromboembolism formation. 
"We are tracking representative blood particles to 
determine the likelihood of platelets becoming 
activated;' Gent said. 
The industry is trying to come up with 
standardized methodologies and a consensus among 
experts about what an acceptable set of boundary 
conditions should be for blood flow through 
branched stent grafts, according to Remund. 
"While developing this model, we were able to 
study how others approached devices, such as left 
ventricular assist devices, that are known to activate 
platelets;' he said. LVADs are pumps that can 
support the blood circulation in patients with 
severely weakened Mldffli'IS?quently tend to 
create s ear effects on the blood. 
'As we continue to push the envelope as an 
industry, we want to make sure we are not creating 
unforseen problems for patients," Remund said. 
Gent said, "We are expanding our portfolio of 
capabilities to evaluate these stents for various types 
of relevant parameters. We are trying to answer 
really tough questions while also being responsible 
as we work through them:' 
Remund added, "Our next focus will be to create 
benchtop models which can validate our input 
assumptions for the computer simulations:' 
"We are trying to 
answer really tough 
questions while also 
being responsible as 
we work through 
them." 
- Stephen Gent, 
associate professor 
mechanical engineering 
This illustration shows a stent graft that Sanford Health 
vascular surgeon Pat Kelly designed and placed within 
a patient who has a bulging thoracoabdominal 
aneurysm. Using computational fluid dynamics 
modeling, associate professor Stephen Gent works with 
biomedical engineer Tyler Remund, a member of Kelly's 
product development team, to evaluate the manner in 
which blood flows through stents, such as this one. A 
Sanford Health animation showing how such a stent 
graft is placed within a patient can be viewed at 
www.youtube.com/watch?v=sEfHnrjzwlk. 
rJ or. r.esea(cb rio· ct ir.is ires ~aduate t eat 
When John Asiruwa came to Brookings in fall 2015 to begin graduatf wor1< in mechanical engineering, 
his first stop tJas the office of associate professor Stephen Gent. 
"I want to be involved in something that can make life better fir ottJirs," he recalls telling Gent. The 
Nigeria native tredits Gent and his work with Sanford Health for i itin his '*1ssion for biomedical 
engineeri 
"Dr. Gent and Sanford Health gave me the opportunity that I need ," said Asiruwa, who will complete 
his master degree with an emphasis in biomedical engineering this year. 
Asiruwa, who earned his bachelor's degree in mechanical 
engineering from the University of Benin, Nigeria, worked 
as a process engineer for a year before deciding to 
go to graduate school. His uncle Christopher 
lgbinedion, who earned his master's degree in 
civil engineering here in 1993, recommended 
his alma mater. 
Gent commended Asiruwa for his 
initiative and enthusiasm: "I have been quite 
impressed with John's abilities-he is an 
asset for our research group." 
For his thesis work, Asiruwa is using 
computational fluid dynamics modeling to 
evaluate how the angle at which the coron 
a{tery branches affects the blood flow and, 
thertfore, the likelihood of clotting and plaqu 
buildu , known as atherosclerosis. This inform on is 
vital when carrying out coronary bypass surgeri and 
placing stents. 
"A stent is difficult to deploy in a coronary artery," he exp ned, 
noting the critical role that blood pressure and flow dynamics play it1 this part of 
the body. 
"The takeoff angle of the left coronary artery makes a differen ," Asiruwa 
said. Based on these analyses, he hopes to identify which angl are associated 
with an increased likelihood of blockages reoccurring. The re~ts will give 
surgeons data to make decisions that will affect patient outl)mes. 
"Understanding the flow dynamics in coronary stenting a,d its complexity will 
help those designing biostents and tissue-engineered degradable stent grafts 
lor more complex aneurysm-prone regions with delicate arterial networks," 
lained Asiruwa. He plans to pursue a doctorate in biomedical engineering and 
es to continue doing research on Sanford Health projects. 
"I come from an area of the world where minimally invasive medical techniques 
re not common," he noted. "I feel I am in the right place. I can see what I am doing 
can be life changing for patients." 
Mechanical engineering graduate student John Asiruwa diagrams the branching of coronary 
arteries. The Nigeria native, who is studying l*lmedical engineering, is modeling blood flow to 
evaluate the ffkelihood of clotting and plaque bulldup In the illeries, known as atherosclerosis. 
-
D-eciding how terminally ill patients want to live-and die-can be complicated. Nurses experienced in palliative and end-of-life care can guide patients and their families through this difficult process, according to associate professor Mary 
Minton, associate dean of the graduate nursing program. 
Minton and assistant professor Mary Isaacson surveyed nurses working in rural and 
urban settings to assess their comfort levels and document the strategies they use to 
communicate with these patients and their families. The research was conducted in 
collaboration with Avera Health and funded through a one-year, $15,000 grant from the 
Hospice and Palliative Nurses Foundation. 
"We are operating against a backdrop of a health-care environment that is more focused 
on a cure model:' Minton pointed out. "We have to embrace the 'letting go' of 
nterventions-that it's OK to do that. This 'letting go' segues to concerns regarding 
stewardship of health-care dollars." 
The nurse-researchers developed and tested an assessment tool called C-COPE, Comfort 
with Communication in Palliative and End-of-Life Care, and invited nurses at six Avera 
Health facilities in eastern South Dakota-four rural and two urban-to complete the 
online survey. Of the 750 to 1,000 registered nurses at these facilities, 277 responded, 
ranking their comfort level on facets of palliative and end-of-life care communication 
ranging from physical symptoms to cultural and religious concerns. 
Greater comfort level among rural nurses 
erall, the respondents reported what Minton termed "a fair amount of comfort:' 
ndividual scores ranged from 26 to 106, with a lower score associated with a higher 
comfort level, and an average score of 47.9. 
Rural nurses, in general, were more comfortable guiding patients through palliative and 
end-of-life care planning than their urban counterparts. "That makes perfect sense, given 
the proximity in which nurses live and work in these rural areas-they are integral to that 
community;' said Isaacson, who worked as a nurse in a rural setting. 
"Research shows that patients are waiting for their health-care providers to initiate these 
discussions," noted Isaacson. "Nurses need to have the ability to initiate these crucial 
conversations and be comfortable talking to patients and families." 
Minton continued, "Nurses are in a position to provide a safe, nonthreatening 
atmosphere where patients can set goals and make decisions about their care. They spend 
more time with patients and are usually more involved in end-of-life care:' 
In 2012, only 25 of South Dakota's 14,762 licensed nurses were certified in palliative and 
hospice care and they tend to practice in an urban setting, Minton explained. Of those 
surveyed, nurses with specialized training of any kind had a slightly greater, though not 
statistically significant, comfort level in three areas-delivering difficult news, dealing with 
spiritual or religiou~ concerns and discussing end-of-life decisions. 
Techniques learned through experience 
The researchers then interviewed five rural and five urban nurses who had an average of 
eight y,ears' experience in home health and hospice care to identify the communication 
strategies they use in guiding patients and their families in end-of-life decision-making. 
"What we found is that their techniques were constantly evolving-there was not a 
linear ethod:' Minton said. "The amount of dexterity these nurses have navigating these 
situations speaks to how at ease they are-they do not question what they do." 
However, the nurses agreed that nothing in their undergraduate education prepared 
them. 
''As new nurses, they could not communicate like this;' Isaacson said. They developed 
these skills through experience, relying on the more seasoned nurses or other health-care 
professionals as role models. 
Five main themes emerged from this qualitative portion of the study. First, the nurses 
established the context by asking the patients, "What do you know about your illness-
where did you start and where have you been?" These nurses want to "hear where the 
person thinks he's at and work from there;' Isaacson reported. 
Second, nurses said they listened attentively to what these patients and their families had 
experienced. "They acknowledged not only the physical and financial losses but also the 
psychological ones-the loss of dignity because of therapies;' Minton explained. "We know 
these conversations are important, but it's also imperative to be comfortable with silence:' 
Third, through the education process, the nurses build a trusting relationship with their 
patients allowing them to understand and prepare for death, according to Minton. "The 
patients know they are not alone and that their wishes will be honored:' 
Fourth, the surveyed nurses understand advanced-care planning and end-of-life 
tlecision-making, more specifically, "the patient and families' wishes and goals of care. 
These nurses knew when they had to be frank:' Isaacson said. They posed questions such as 
"Is there something you need to accomplish before you die, while you are still physically 
able?" 
Finally, honesty was interwoven throughout their conversations with patients and 
families. The nurses often stated that repetition and "presenting reality" were essential, 
Minton said. "These nurses can be truthful without being apologetic." 
Integrating these strategies and communication techniques into the nursing curriculum 
and professional workshops is essential to providing competent end-of-life care. 
Mary Minton Mary Isaacson 
mericans struggling to lose weight often resort to a low-
carbohydrate diet, but a newer food ingredient, known as 
esistant starch type 4 or RS4, may allow them to add 
some bread products back into their diets while also improving 
their health, according to Moul Dey, associate professor in the 
Department of Health and Nutritional Sciences. 
RS4, a nondigestible, chemically modified wheat fiber, works 
as a functional fiber with prebiotic properties, explained Dey, 
whose research group studies the role of biologically active 
dietary components in chronic diseases. Unlike simple 
carbohydrates, which are broken down into sugars in the small 
intestine, RS4 resists digestion and passes into the large intestine. 
"Gut bacteria use it as fuel, releasing beneficial compounds, 
such as short-chain fatty acids, that are generally believed to keep 
you healthy. Since RS4 isn't digested, we absorb fewer calories 
from foods that are high in this type of carbohydrate;' Dey said. 
Other researchers have studied RS4 in healthy adults, but Dey 
and her team are the first to examine the impact of RS4 in 
mitigating metabolic syndrome, which affects one-third of 
American adults. The combination of high blood pressure, high 
blood sugar levels, high cholesterol and abdominal fat make 
those with metabolic syndrome three times more likely to have a 
heart attack or stroke, and five times more likely to develop Type 
2 diabetes, according to the International Diabetes Federation. 
The research was supported by MGP Ingredients, the 
National Institutes of Health and the U.S. Department of 
Agriculture through the South Dakota Agricultural Experiment 
Station and involved collaboration with U.S. Food and Drug 
Administration scientist Ali Reza Fardin-Kia. 
Other SDSU collaborators were assistant professor Lacey 
McCormack from the Department of Health and Nutritional 
Sciences, associate professor Howard Wey from nursing, 
professor Jeffrey Clapper from animal science and professor 
Bonnie Specker, director of the E.A. Martin Endowed Program in 
Human Nutrition. 
Four peer-reviewed articles have been published on their 
findings since 2014. Two doctoral students, one master's degree 
student and a postdoctoral researcher worked on the RS4 
research. 
Improving symptoms of metabolic syndrome 
The human clinical trial study involved adults from two 
Hutterite colonies in eastern South Dakota. Typically, Hutterite 
diets are high in protein, fat, cholesterol and salt and low in fiber 
compared to the recommended dietary allowance, Dey noted. Of 
the 83 participants who completed the trial, 40 had metabolic 
syndrome and most were on prescription medications for one or 
more of those conditions. 
Unlike most dietary intervention studies, the researchers used 
a free-living, community-style environment and made minimal 
modifications to the participants' habitual diet. The intervention 
was blinded, meaning the participants did not know if they were 
consuming the RS4 or the control flour at a given time, Dey 
explained. "Blinding was possible because the neutral sensory 
properties of RS4 make it undetectable in foods." 
RS4, which is currently available only to food manufacturers, 
was incorporated into the intervention group's flour. All meals in 
this communal setting are prepared from scratch and every meal 
contains one or two flour-based items. 
The intervention was conducted in two 12-week sessions with 
a two-week hiatus. This allowed researchers to switch the 
intervention and control-diet groups so that each group served as 
its own control. Stool and blood samples were collected and a 
DXA scan to evaluate body composition was done before and 
after the intervention. 
Use of resistant starch decreased all types of cholesterols, Dey 
reported. The participants' baseline cholesterol levels were not 
high, in part, because of the medications they were taking. 
Despite that, the participants' average total cholesterol dropped 
significantly after the intervention. In addition, the researchers 
observed a small but significant decrease in average waist 
circumference and body fat percentage. Markers of inflammation 
in blood were lowered as well. 
DNA analysis of stool samples using next-generation 
sequencing showed that RS4 can improve bacterial composition, 
according to Dey. "Changes in the gut microbial community 
correlated with improved indicators of metabolic health as well 
as increased short-chain fatty acids." 
In particular, commonly regarded good bacteria, like 
Bifidobacterium adolescentis, Parabacterium distasonis and the 
newly described species, Christensenella minuta, increased in 
response to consuming 9 grams, or approximately 0.3 ounces, of 
RS4 per day for 12 weeks. 
Examining inflammatory gene expression 
Some of the inflammation-lowering effects of RS4 found in 
humans were also confirmed through a mouse model study. The 
researchers found that butyrate, one of the short-chain fatty acids 
produced by the gut bacteria, increased in mice fed a diet 
supplemented with 20 percent RS4 for 12 weeks. Results were 
published in the September 2016 issue of Food and Function. 
"Everyone is born with a genetic blueprint that rarely changes 
during their lifetime, but diet and environment can epigenetically 
change how genes function without changing the genetic code;' 
she said. Other researchers have shown that higher levels of 
butyrate translate to a healthier bowel and a lower risk of 
inflammation. "We observed that butyrate-induced suppression 
of pro-inflammatory genes was accompanied with a specific type 
of epigenetic change that was not shown before;' Dey said. 
"Our research shows that potentially tailoring a more healthy 
diet that also tastes familiar and good is possible;' she concluded. 
This is critical to mitigate some of the long-term dietary 
compliance issues often faced by public health promotion 
programs aiming to curtail the rising trend in obesity and 
metabolic diseases. 
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From top: Resistant starch type 4, a nondigestible, 
chemically modified wheat starch, in the container 
directly below the bread, has neutral sensory properties 
that make it undetectable in foods. One of the samples 
on the right has it, while the other does not. 
A DXA scan of each participant before and after the 
intervention allows researchers to evaluate changes in 
body composition. 
Associate professor Moul Dey and master's degree 
student Robert Juenemann review test results that 
assess the proinflammatory proteins in the bloodstream 
of study participants. 
Dey, doctoral candidates Bijaya Upadhyaya and Yi Liu and 
postdoctoral researcher Saileodra Nichenametla examine 
human colon cells treated with short-chain fatty acids, 
which helped reduce inflammation. 
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From top: This microscope image shows immune 
cells, in green with blue nuclei, that have 
internalized H1 N1 viral particles. Those in red are 
responding to the therapeutic antibody SA8100. 
These images allow the researchers to assess 
how effective different antibodies are at mediating 
clearance of viruses by immune cells. 
Doctoral student George Opoku-Kusi and 
postdoctoral researcher Svetlana Kurilova use 
high-throughput microscopy to study how immune 
cells clear influenza virus from the body. 
Using a flow cytometer, research associate Jason 
Kerkvliet measures populations of single cells to 
determine how they recognize the antibody 
therapeutic. 
To determine the specific antigen site to which the 
therapeutic antibody binds, doctoral student 
Rongyuan Gao prepares an antibody solution, 
which is part of an enzyme immunoassay to 
detect and measure which influenza antigens the 
antibody targets. 
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Researchers investigate 
workings of anti body 
therapeutics 
W en it comes to emerging viruses, such as a new strain f influenza, antibody therapeutics can save lives. They an be developed quickly and used to rapidly eliminate 
the virus from an infected person's body. 
However, how to make the best therapeutic antibodies is not 
very clear, according to professor Feng Li. The virologist is part of 
a team of BioSystems Networks and Translational Research 
(BioSNTR) researchers investigating how antibodies protect the 
body from influenza virus. The collaborative project, which began 
in June 2015, looks at how the antibodies recognize their targets, 
activate immune cells and clear influenza from the body. 
Cell biologist Adam Hoppe, BioSNTR director and associate 
professor at SDSU; immunologist/virologist Victor Huber, an 
associate professor at the Sanford School of Medicine of the 
University of South Dakota; and Li are evaluating and coming up 
with new ways to predict the efficacy of antibody therapeutics 
produced by Sioux Falls-based SAb Biotherapeutics (SAB). The 
biopharmaceutical company's immunotherapy platform was 
recognized by the World Health Organization as a one of the top 
platforms for rapidly responding to infectious disease outbreaks. 
Huber's research focuses on understanding host antibody 
responses that are associated with vaccine-induced protection 
against influenza viruses. A BioSNTR seed grant to perform initial 
trials on an influenza therapeutic helped SAB and Huber secure a 
Small Business Innovation Research Grant from the National 
Institutes of Health last fall to advance its treatment for influenza. 
"BioSNTR creates an opportunity to bring components of 
biomanufacturing-including antigen development-to the state 
of South Dakota:' said SAB president and CEO Eddie Sullivan. 
"BioSNTR scientists have the refined skills and advanced 
capabilities to help us develop laboratory tests to show that our 
antibodies are effective." 
Delivering protection quickly 
''A vaccine mimics the primary viral infection and, thus, 
stimulates the immune system to generate antibodies;' Li said. 
That produces what is known as an immune memory, but that 
takes from a few weeks up to a year. When a patient receives a 
yearly flu shot, it then reactivates that memory and causes new 
antibodies to be produced that protect against current strains of 
influenza. 
"In contrast, antibodies can induce an immune response 
quickly or they can be used in a preventative way:' Li said. The 
antibodies will block any recognizable viruses and can be used 
during an outbreak, either before or after the patient is exposed. 
The antibodies live in the bloodstream anywhere from several 
weeks to several months. 
''Antibodies are only temporary, but sometimes temporary 
can be critical;' Li continued, referring to an influenza pandemic 
or Ebola outbreak. For those with weakened immune systems, 
such as the elderly, or those with immunosuppressive diseases, 
such as HIV, antibody therapeutics may be their only viable 
option. 
As part of the BioSNTR team, Huber, who has been doing 
influenza research since 1997, makes the influenza vaccines, which 
SAB then uses to generate the antibodies from which the 
therapeutics are made. He then utilizes a ferret model to test the 
effectiveness of the end product. 
Feng Li Adam Hoppe 
"This allows us to work out the dynamics of the therapeutics;' 
he said. That includes the timing and duration of the injections, 
as well as the dose needed to produce a protective response. 
"We know how much antibody is needed to get protection 
against influenza from a vaccine, but that amount from a 
therapeutic is not known;' Huber noted. 
Unraveling inner workings 
"We are helping them figure out the protective mechanism of 
the antibody;' Li explained. "To be effective, the antibody must 
recognize the virus and then send the immune system to kill the 
virus." 
Li's group uses a molecular approach to figure out where the 
antibody binds. The surfaces of influenza virus particles have 
numerous copies of spike-like projections, known as antigens, 
which the antibodies recognize and adhere to, essentially marking 
them for destruction by the immune system. Two doctoral 
students and research assistant professor Dan Wang work with Li 
to map the specific antigen sites, which the antibodies target. 
Because the vaccines used to produce the antibody 
therapeutics cover multiple strains, the number of antigens to 
which the antibodies bind indicates the range of the immune 
response. Huber said, "Inducing a broad immune response will 
help make a better product:' 
Hoppe's group focuses on what's happening at the cell level-
how the immune system recognizes the antibodies attached to the 
virus and then clears the virus from the body. One doctoral 
student is working on this project. 
Immune cells, such as macrophages and dendritic cells, have 
Fe-gamma receptors that recognize the antibodies attached to the 
virus. The macrophages an other specialized immune cells then 
ingest and destroy the virus. 
In addition, the virus also invades body cells and begins 
producing more virus. When that happens, the viral proteins, or 
antigens, appear on the cell surface, Hoppe explained. Antibodies 
detect these and attach to the infected cells. Through the Fe-
gamma receptors, the macrophages and natural killer cells 
recognize the attached antibody and kill the infected cells. 
To understand how the immune cells clear the antibody-
coated viruses and antibody-recognized infected cells from the 
body, Hoppe said, "We develop assays to measure how well the 
antibody mediates this clearance process." 
Though antibody recognition is diverse, Huber noted, "There 
are only a handful of ways the host eliminates pathogens." His lab 
works on the whole antibody in relationship to the Fe-gamma 
receptors. 
"We are looking for ways to optimize those interactions to 
clear the infection more rapidly, especially in the case of a severely 
infected individual;' he added. 
What the BioSNTR researchers learn will not only help SAB 
improve its influenza therapeutic, but also result in technologies 
that other biottchnology compani1s c use to evaluate product 
effectiveness. 
DNA, RNA 
sequencing available on 
campus to researchers statewide 
To determine what mechanisms help perennial plants survive the winter or how cancer triggers uncontrolled cell growth, scientists must look within an organism's 
genetic code. To figure out what is happening, many university 
researchers must send their samples to large sequencing 
facilities and wait, sometimes months, for results. 
That is no longer necessary at South Dakota State University. 
Instrumentation that can sequence the entire genome of an 
organism is now available on campus, thanks to funding from 
the National Science Foundation, Agricultural Experiment 
Station, SDSU Division of Technology and Security and South 
Dakota's BioSystems Networks and Translational Research 
(BioSNTR) Center. 
"Having a sequencing center in South Dakota allows 
researchers to rapidly acquire genomic data, conduct 
bioinformatics analyses and then refine their experimental 
designs:' said BioSNTR Director Adam Hoppe. 
"High-throughput genome sequencing is not an option 
anymore-this is something researchers have to do to get 
funded:' said Department of Agronomy, Horticulture and Plant 
Science associate professor Jose Gonzalez, who led the team that 
secured funding. 
Gonzalez and department colleagues assistant professor 
Sunish Sehgal and associate professor Senthil Subramanian as 
well as biology and microbiology professor Heike Bucking were 
awarded a three-year, nearly $350,000 NSF equipment grant in 
fall 2015. The Agricultural Experiment Station and the SDSU 
Division of Technology and Security provided an additional 30 
percent in matching funds. 
Gonzalez oversees the genome sequencing laboratory at the 
Young Brothers Seed Technology Laboratory, which houses the 
Illumina NexSeq 500 nucleic acid sequencer along with 
accompanying instrumentation to prepare samples. The lab 
offers fee-based sequencing services to researchers at 
universities and biotechnology firms. Since opening last 
summer, more than 150 samples have been sequenced. 
Suited to researchers' needs 
"We have a full suite of instruments," Gonzalez said, noting 
that this model was chosen because "it fits the amount of output 
that a typical project needs." Through support from the 
Department of Agronomy, Horticulture and Plant Science and 
BioSNTR, the researchers also hired a full-time technician, 
Michaellong Tran, to prepare samples and do the sequencing. 
"We can do a run for one single project:' Gonzalez pointed 
out, which means faster turnaround times. "Having a facility 
here also makes it easier to adapt this technology for 
investigators who are not familiar with sequencing." 
The machine has the capacity to do one or two human 
genomes in a single run, with an estimated run time of 30 
hours. However, plant genomes can be larger than human 
genomes, Gonzalez noted. 
Jose Gonzalez 
As the SDSU winter wheat breeder, Seghal said the next-
generation sequencing facility"will increase the precision in 
gene transfers. It will help us develop genomic prediction 
models so that we can deliver better genetics and varieties to 
South Dakota producers." 
Analyzing gene expression 
"We can sequence DNA or RNA:' he said, noting that there 
is more demand for the RNA sequencing option. "RNA 
represents all of the genes that are being expressed at any given 
point in time and in any given tissue-the working machinery." 
For example, a researcher can grow one plant in normal soil 
and another in high salinity soil and then look at the differences 
in gene expression between the two plants. "You might have 
only a few hundred genes differentially expressed-some are the 
cause of the difference, while others are the effect of that 
difference:' he explained. "That gives you a good point from 
which to start." 
Researchers then combine their findings with other evidence 
or data to get a better understanding of what's happening. 
"Nothing gives you a magic solution in science:' Gonzalez 
noted. 
"The infrastructure and collaboration that has been made 
possible through BioSNTR have given my research group new 
tools to identify the genes involved in soybean nodule 
development:' Subramanian said. His research aims to increase 
the nitrogen-fixing power of soybeans. 
Specifically, Subramanian's research group is examining 
which microRNAs direct gene expression when pre-existing 
root cells are transformed into two distinct regions-one that 
fixes nitrogen and the other that transports it to the plant For 
this NSF project, the research team needed to optimize new 
methods for construction of gene expression libraries from a 
small number of cells. 
The availability of in-house sequencing enabled graduate 
student Sunita Pathak to customize available methods and select 
the most efficient one for constructing gene-expression 
libraries. 
Through funding from the Sun Grant Initiative, Gonzalez 
and his collaborators will sequence the full prairie cordgrass 
plant genome. "To my knowledge, this will be the first complex 
genome sequenced all in-house in South Dakota:' he said. 
Prairie cordgrass is a potential feedstock for biofuel production. 
"It's more than efficiency:' Gonzalez noted. "It's actually 
allowing us to do things we couldn't do before. It's as simple as 
that." 
-, ~ 
From top: Research associate Michaellong Tran 
loads reagents into a programmable pipetting 
machine that extracts DNA from samples. 
Having an in-house genome sequencing facility 
shortens turnaround time for SDSU researchers 
identifying the genes involved in soybean nodule 
development. 
Tran analyzes a sample to check for DNA/RNA 
fragment size and quality. 
Tran and associate professor Jose Gonzalez 
examine settings on the genome sequencer. 
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From top: This bulb-like section shows that this 
grapevine has been grafted, meaning the root 
system is genetically different from the top 
portion that produces the stems, leaves and fruit, 
referred to as the scion. QUBIC-R will help 
unravel the genetic interactions taking place. 
Photo courtesy of associate biology professor 
Allison Miller of Saint Louis University 
QUBIC-R analyzes RNA datasets from 
switchgrass (center) and Arbidopsis, a small 
flowering plant (bottom), faster than three other 
popular programs-Plaid, Xmotifs and Quest. 
At right: The ability to visualize co-exwession 
networks is one of the major strengths of QUBIC-
R. The colors identify the interacting groups 
within the network. The dot size signifies the gene 
interactions taking place and the connecting line 
width shows dynamics of those interactions. 
QUBIC-R can be downloaded for free using the QR 
code below. 
https://bioconductor.org/packages/ 
release/bioc/html/QUBIC.html 
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OUBIC-R 
software helps researchers model, 
visualize gene expression networks 
Determining the order of the DNA nucleotides-adenine, guanine, thymine and cytosine-that make up an organism through next-generation sequencing technologies has become 
commonplace. However, generating that code of life is only the 
beginning. 
Genome News Network compares a genome to "a book written 
without capitalization or punctuation, without breaks between words, 
sentences or paragraphs, and with strings of nonsense letters scattered 
between and even within sentences:' 
To make sense of these big datasets, scientists partner with 
specialized statisticians who develop algorithms and software that help 
researchers decipher what's happening within the code. 
That is where the work of assistant professor Qin Ma comes in. He 
developed software called QUBIC to help analyze RNA gene expression 
data in 2009 as part of his doctoral work. He completed joint 
doctorates in operational research from China's Shandong University 
School of Mathematics and in computational systems biology from the 
University of Georgia. 
Now he's updated the software, increasing its efficiency and adding 
new visualization capabilities. Ma came to SDSU nearly two years ago 
as a BioSystems Networks and Translational Research (BioSNTR) 
faculty member in the Department of Agronomy, Horticulture and 
Plant Science and holds a joint appointment in the mathematics and 
statistics department. 
Analyzing big datasets 
"He develops tools to help life science people make sense of their 
data more efficiently:' explained professor Anne Fennell, who has been 
doing genomic research on cold-hardy grapes for nearly 20 years. 
Through a National Science Foundation-funded project, she and Ma 
wi!l .. nalp,•bowgraOio g affects rnl,j-djmatLg£, s.Gr '1'.'5...Jll~ __ 
commonly grafted, so the root system is genetically different from the 
top portion that produces the stems, leaves and fruit. 
"Plant scientists spend a tremendous amount of time going through 
these big datasets-anywhere from 2 million to 12 million data points:' 
Fennell explained. "One of the unique features of QUBIC is that it can 
effectively analyze these large biological datasets:' 
In analyzing RNA from spe_ci~<;_ segme\!..~~ ,!h; genetic code, 
scientists seek to determine w~ii.atto'mHi'phre among the genes. 
"Some genes are very_ ti.,ghtly connected, while others are not:' Fennell 
po~~e QUl. Tradiri6ilR§.6stering looks at the genes under one 
condition, such as level of expression. However, the relationships are 
often more complex with patterns changing over time. 
Ma's software uses biclustering to identify whether these genes are 
co-expressed under varying conditions, such as different temperatures, 
messes or daylen,gth. 
"7sing biclM\e~we are getting things that are more similar:' 
Fennell explained. Ma added, "Identifying biclusteripi,l1~1ps elucidate 
the overall regulatory system and gene expressioi9rf~:· 
Making QUBIC faster 
To improve the program's efficiency, Ma ~mented the program 
using R, a commtgfj~uage that statisticians and bioiAfol'11¥1ticians 
use. That decreased the average run time by 82 percent compared to the 
previous version, which was coded in the C language, Ma explained. 
"Efficiency is very important in the big-data era:' 
b2764 
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Qin Ma 
To test the software, Ma input data containing 900 million elements 
and processed them in 30 minutes. "This software is very robust-and 
can be applied to all kinds of data:' added Fennell, including datasets 
generated by animal scientists, microbiologists and virologists. 
QUBIC-R outperformed three popular analysis packages on five 
RNA datasets-E-coli bacteria, the small flowering Arabidopsis plant, 
grapes, a human tumor and switchgrass-as detailed in an article the 
re.searchers published in the November 2016 issue of Bioinformatics. It 
is the official journal of the International Society for Computational 
Biology, the leading professional society for computational biology and 
bioinformatics. 
QUBIC-R is an open access software available free through 
Bioconductor, one of the nation's largest bioinformatics companies. 
"Having it on Bioconductor means that it's readily available and being 
used globally:' Fennell said. 
Furthermore, Ma pointed out, "You do not have to be a 
bioinformatician to use this program:' 
Fennell added, "Even those with not a lot of computational 
background should be able to easily use the program." 
Visualizing relationships, setting up experiments 
QUBIC-R also features enhanced means of visualizing gene 
expression and looking at specific genes within a network. The software 
not only creates heat maps which show the level of gene expression 
based on color intensity in identified clusters, but can also generate co-
expression networks that visualize the importance of specific genes 
within those networks. 
Researchers want to know, not only how they are connected, but 
also how strong those connections are, explained Ma. The software 
allows the researchers to delete data from specific genes and thereby 
J-gy t · il}l Qrtan ' in the p~9,\ogic.al network.. 
Using co-expression network, he said, "we can see through the size 
of the circle ( that represents a specific gene) when more interactions 
are taking place. The thickness of the lines ( or connections) also gives 
you more of the dynamics." 
Experiments are designed to test a hypothesis. Therefort,'.l2i};f 
researchers tend to focus on parameters related to their hypotll.eses. By 
using QUBIC-R as a computational tool, resea1ffllni5!5? do 
"hypothesis-free" data exploration. 
"This type of computatioµal •galysis can show you what you might 
be missing because of that hypothesis-driven focus:' Fennell said. 
Through his role in BioSNTR, Ma helps researchers design their 
experiments, determining how many samples to prepare and what kind 
of sequencing is suitable to test the hypothesis. "It's very important to 
think computationally when you are developing yout 6i1gm-ients:' Ma 
said. 
Fennell adcltcf, l'~hl can suggest tweaks in experimental design that 
will give you better analysis in the end. BioSNTR is about teams coming 
,agether to solve a problem by identifying~~~ weren't able to do 
~fore." Bioinfo~ijend the analytical tools that Ma develops hel£ 
make this possib1e: - o34o0 
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viruses 1n 
IMPOR ED FEE 
INGREDIENTS 
searchers must use a global perspective to assess the risk that foreign animal 
diseases pose to the pork industry and the pathways through which these 
athogens might reach the United States, according to Paul Sundberg, executive 
director of the National Pork Board's Swine Health Information Center. 
One of those pathways may be through imported feed ingredients. 
Scientists from the South Dakota Animal Disease Research and Diagnostic 
Laboratory, collaborating with Scott Dee, director of research at Pipestone Veterinary 
Services in Minnesota, discovered that porcine epidemic diarrhea virus (PEDV) can 
survive a simulated trip from Beijing, China, to Des Moines, Iowa, in five feed 
ingredients. The study was funded by the National Pork Board. Their results were 
published in BMC Veterinary Research. 
Those findings led to a subsequent project exploring whether 10 other viruses might 
also survive the transglobal journey. The study began in March 2016 and is supported by 
the Swine Health Information Center, which began operation in 2015. 
"We need to be better at being able to manage emerging diseases because they are 
going to happen;' Sundberg said. Headquartered in Ames, Iowa, the center monitors 
foreign pathogens to help veterinarians and producers respond to emerging diseases. 
Identifying viability of PEDV in feed ingredients 
"When PEDV broke out in 2013, there was some suspicion that feed was involved in 
some manner, but we didn't know for sure how that could happen-we had no data," 
Sundberg said. 
In January 2014, sows and gilts in three herds on farms with high biosecurity levels 
came down with PEDV. "These were very biosecure farms that were free of PRRS 
(porcine reproductive and respiratory syndrome) and other viruses for many years;' Dee 
said. "It was like someone flipped a switch and the commonality was an emergency feed 
outage:' 
Dee worked with ADRDL director Jane Christopher-Hennings and professor Eric 
Nelson to prove that contaminated feed triggered the outbreaks. They then investigated 
whether the virus could survive in 14 ingredients that are commonly shipped to the 
United States from China. 
The researchers used an environmental chamber, which Pipestone Veterinary Services 
purchased and donated to ADRDL, to replicate the environmental conditions in 
shipping containers during the 37-day journey from Beijing through the port of entry in 
San Francisco to Des Moines. The temperatures and relative humidity simulated a Dec. 
23 through Jan. 28 trip, a timeline associated with the April PEDV outbreak. 
Results showed that PEDV can survive the journey in five feed ingredients-vitamin 
D, lysine, choline and organic and conventional soybean meal. The study concluded that 
"soybean ingredients can potentially present a considerable risk for transboundary 
spread of PEDV:' 
Approximately 7,300 tons of conventional and organic soybeans were imported from 
China in 2013 and 2014, according to information from the U.S. International Trade 
Commission Harmonized Tariff Schedule. 
In addition, the researchers tested several compounds that could potentially decrease 
the risk of live viruses in feed. 
"This was the first research of this type in the world;' Dee noted. "This is a well-
coordinated project that is trying to solve real-world problems." 
Eric Nelson Diego Diel 
Assessing risks from other viruses 
Assistant professor Diego Diel said, "The next logical question is what other high-
impact viruses could be potentially coming into the country through contaminated feed 
ingredients." The virologist leads the team of two research associates and one visiting 
scientist who are assessing 10 key viruses using the transglobal environmental model. 
Diel and Dee worked with Sundberg to select the high-priority animal diseases, three 
of which are already in the United States-PRRS virus, vesicular stomatitis virus and 
circovirus. "Viruses from the same family with similar characteristics are used as 
surrogates for the viruses not present in the United States;' Diel said. 
The first phase of the project examined Senecavirus A as a substitute for foot and 
mouth disease virus, bovine viral diarrhea virus as the surrogate of classical swine fever 
virus and bovine herpes virus- I for pseudorabies virus. Other diseases for which the 
group is using surrogate viruses are Nipa virus, vesicular exanthema virus and 
enterovirus. 
"We prioritized the diseases according to the potential impact on domestic and 
international markets, economic effects on production and likelihood that they could be 
introduced or, if already in the country, could emerge as a problem;' Sundberg explained. 
About half these diseases have strains that infect other animal species, which gives this 
study an even broader impact. 
In selecting feed ingredients, the researchers focused more on grounaingreaients, 
adding moist dog and cat food, dry dog food and pork sausage casing to the list. "To 
make it a more diverse list, we looked at what comes into the San Francisco port of 
entry," Dee said, noting that the U.S. ships pig bladders, stomachs and intestines to China 
for processing. The sausage casings represent the import of these processed products 
back into the United States. 
Impacting animal health 
"This is an extremely important project, one which, to my knowledge, has never been 
done before in any species. It identifies potential risks to animal health in the United 
States from importing different products that you might not think could be a risk;' 
Sundberg said. 
The experiments will be completed this spring and analyses of results are ongoing, 
according to Diel. 
"We're seeing differences in virus survival across virus types and ingredient types. 
Identifying those high-risk combinations will be an important outcome," Dee explained. 
"We will have some powerful stories to tell based on science, not just speculation:' 
Sundberg said, "The issue comes down to being better prepared for new, emerging 
diseases and more knowledgeable of the risks:' 
As Nelson puts it, "The ultimate goal is to protect U.S. agriculture:' 
From left: These vials contain feed ingredients, such as soybean meal, soy oil cake, dried distillers grain solids, 
lysine, choline, Vitamin D, moist and dry dog food, moist cat food and sausage casings. 
Research associate Aaron Singrey places vials containing feed ingredients into an environmental chamber 
programmed to replicate changes in the temperatures and relative humidity during shipping from China to Des 
Moines, Iowa. 
Visiting scientist Marcello Delima adds a buffer to recover virus from the samples. 
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Gene linked to hormone that impacts 
soybean-nod u I e development 
Suresh Damodaran, a doctoral candidate in the Department of Agronomy, Horticulture and Plant Science, has been 
awarded a Joseph F. Nelson Graduate 
Scholarship for research identifying a gene 
that is linked to a hormone that affects 
soybean-nodule development. The 
scholarship recognizes outstanding graduate 
students for their original scientific research, 
providing $2,500 for tuition and fees. 
Damodaran's research is part of a National 
Science Foundation project to identify the 
genetic mechanisms that direct and 
coordinate formation of the soybean nodule. 
Through this project, associate professor 
Senthil Subramanian hopes to increase the 
plant's ability to fix nitrogen and thus reduce 
the need for chemical fertilizers. 
"This scholarship is a big motivation for 
my research and for my future career:' 
Damodaran said. He came to South Dakota 
State University in 2010, earning his master's 
degree in plant science December 2012 and 
then continuing in the doctoral program. He 
will complete his doctorate in plant molecular 
biology this year and hopes to find a 
postdoctoral position working on plant 
genetics. 
"Suresh is very bright, enthusiastic and 
self-driven:' Subramanian said, noting that 
Damodaran not only conducts his own 
experiments but also trains undergraduates in 
plant biology research. "The award is a well-
commitment and hard work toward his 
research goals. It's a pleasure to have him on 
my research team." 
Damodaran praised Subramanian as "an 
excellent mentor who is always available and 
open to suggestions. He introduces new ideas 
every week about research in other labs and 
encourages us to come up with our own 
ideas:' 
Identifying gene expressions 
The soybean plant, a legume, interacts 
with bacteria in the soil to form organs called 
nodules, explained Damodaran. Within the 
nodules, two distinct zones--0ne that fixes 
the nitrogen and another that transports it to 
the plant-are formed from the pre-existing 
root cells. The expression of specific genes in 
a particular root cell determine its function. 
Through their previous studies, 
Subramanian's group found that the auxin 
hormone reduced nodule numbers. As part of 
a large-scale experiment to identify which 
genes are expressed in the nodule tissue, 
Damodaran focused on auxin production and 
identifying the genes regulating auxin levels 
in the nodules. That quest led him to the 
SUR2gene. 
"If we consider genes as workers involved 
in constructing the nodules to determine one 
particular gene's function, we take that gene 
or worker out of the system and see how the 
construction goes," Damodaran said. 
However, he noted, soybean genes usually 
belong to huge families. As a result, when one 
is taken out, another takes its place. 
Linking gene, auxin production 
When Damodaran reduced the expression 
of the SUR2 gene, thus increasing auxin 
production, the plant produced fewer 
nodules. Conversely, when he treated the 
plant with a chemical that reduces auxin 
levels, the nodule numbers increased. 
In addition to supporting the group's 
initial evidence regarding auxin's role in 
nodule development, Damodaran is the first 
plays in this process. 
"This guy is really important:' Damodaran 
said. Plants typically use an amino acid called 
tryptophan to make other compounds and as 
a precursor from which auxin is produced. 
However, he added, "When this gene is 
suppressed, all the available trytophan flows 
toward auxin production." 
Despite the significance of this finding, 
Damodaran said, this is just one piece of the 
bigger model that will ultimately help the 
researchers optimize overall nodule 
development. 
Measuring research investments 
Funding source for FY 2016 
expenditures through grants 
and contracts 
Total $46,797,995 
• Nonfederal 
• Other federal U.S. Dept. of Education 
• U.S. Dept. of Tranportation 
• U.S. Dept of Interior 
• NASA 
• U.S. Dept. of Defense 
• Health and Human Services 
• U.S. Dept. of Energy 
• National Science Foundation 
• U.S. Dept. of Agriculture 
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Doctoral student Suresh Damodavan examines soybean seedlings that have been genetically altered. These experiments 
helped him discover the key role that the SUR2 gene plays in nodule development. 
FY 2016 expenditures through grants 
and contracts presented by colleges 
and research centers 
Total $46,797,995 
• 
Others 
D Pharmacy and Allied Health Professions 
• 
Arts and Sciences 
E. A. Martin, Human Nutrition 
• Geospatial Sciences Center of Excellence 
• Education and Human Sciences 
• Sun Grant 
• EPSCoR Jerome J. Lohr College of Engineering 
• Agriculture and Biological Sciences 
Ag engineering doctoral student develops 
separation methods for bi of u e I 5 
Work on two biofuels projects has earned Agricultural and Biosystems Engineering doctoral 
student Yuhe Cao the Joseph F. Nelson 
Graduate Scholarship. The award recognizes 
outstanding graduate students for their 
original scientific research and provides 
$2,500 for tuition and fees. 
Cao has developed separation methods 
that will add value to biofuels research aimed 
at producing jet fuel from camelina and 
biobutanol from plant materials. The 
research is supported by the U.S. Department 
of Energy through the Sun Grant Initiative, 
which supports the development of 
renewable, biobased energy technologies, and 
the South Dakota Oilseeds Initiative. 
After earning his master's degree in 
material processing in 2009 from Tianjin 
Polytechnic University, Cao worked at a 
membrane filtration and separation company 
for four years before coming to South Dakota 
State to pursue his doctorate. 
"I am honored to be one of the 
scholarship recipients:' Cao said. "This will 
motivate me to work hard and achieve 
excellence in my research during the rest of 
my tenure at SDSU and beyond." He plans on 
completing his doctorate this year and hopes 
to get a position in academia that allows him 
to continue research in separation science 
and technology. 
"Yuhe's industrial experience and passion 
for developing new separation technologies 
have been integral to his success," said Cao's 
adviser, associate professor Zhengrong Gu. 
"His dedication to excellence in research has 
made him an asset to my team and to this 
university." 
Separating byproducts from camelina 
Cao has developed a new method of 
separating a compound called glucosinolate 
from camelina, a broadleaf oilseed from the 
mustard family. Glucosinolate is one of the 
bioactive compounds that remains after the 
oil has been extracted, according to Gu. The 
presence of glucosinolate limits the amount 
of camelina meal that can be incorporated 
into animal diets to 10 percent. 
"It's very toxic;' he pointed out, and it's 
that toxicity that Gu wants to utilize-to kill 
fungus and weeds or even cancer cells. 
Cao extracts the glucosinolate with 
ethanol and then uses membrane filtration to 
remove impurities, such as proteins. Then he 
uses an ion exchange column to further 
purify the glucosinolate. 
"If we recover it and, at the same time 
give the solids back to use as animal feed, we 
have a win-win game:' Gu said. 
Extracting biobutanol 
In addition, Cao also developed a more 
efficient, less energy-intensive means of 
separating butanol from the fermentation 
broth that produces acetone-butanol-ethanol 
from lignocellulosic biomass. Biobutanol has 
a higher energy content than ethanol and can 
be used in conventional gas engines without 
modifications, according to biobutanol.com. 
"One of the main issues in acetone-
butanol-ethanol fermentation is that butanol 
concentrations in the fermentation broth are 
low, ranging from 1 to 1.2 percent in weight, 
because of its toxicity to the microorganisms;' 
Cao noted. 
New solid extraction separation methods 
that add substances, such as polymer resin 
and zeolite or activated carbon, to the 
biobutanol fermentation broth to adsorb the 
butanol can recover only low concentrations 
ofbutanol and damage the fermentation 
microorganisms. Though another new 
recovery method, known as gas-stripping 
condensation, improves the fermentation 
process, it still requires expensive liquid 
nitrogen. 
Cao's process uses helium to do the gas 
stripping and then a column with activated 
carbon fabricated from cornstalks more 
efficiently recovers butanol from vapor 
stream. Because the method continually 
captures butanol while preserving the 
fermentation microorganisms, it recovers 
butanol in higher concentrations while 
consuming less energy than traditional 
methods. 
"This is a much more efficient way of 
separating butanol;' Gu said. "It saves lots of 
energy." The research team has filed an 
invention disclosure on the helium-based 
gas-stripping separation method. 
Woll<ing with associate professor Zhengrong Gu, doctoral student Yuhe Gao, right, carefully inserts a tube loaded with activated carbon fabricated from cornstalks into the chemisorption 
analyzer. The butanol-recovery process that Gao developed separates more butanol using less energy than other methods. 
Total research expenditures FY 2009 - 2016* 
Million 
$70 
$60 
$50 
*These figures are the sum of 
expenditures from grant and contracts, 
funds appropriated to the South Dakota 
Agricultural Experiment Station and 
other institutional funds allocated to 
research. 
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Research expenditures increase 
Overall, FY2016 expenditures through grants and contracts rose by 7.53 percent, 
approximately $3.28 million, compared to FY2015. 
Although the College of Agriculture and Biological Sciences continues to account for a lion's 
share of research dollars- approximately 38 percent, other colleges have seen large gains in 
research funding in the last fiscal year. The College of Pharmacy and Allied Health Professions 
more than doubled its research funding, going from $432,290 in FY2015 to nearly $950,000 in 
FY2016, while the College of Arts and Sciences experienced nearly a 30 percent increase during 
that same period. 
In assessing changes in the levels of funding by agency, the university had a 45 percent 
increase in Department of Education funding from FY2015 to FY2016, an approximately 24 
percent increase in Department of Health and Human Services funding, a nearly 20 percent 
increase in NASA funding and close to a 10 percent increase in funding from the National Science 
Foundation. In addition, for the second year in a row, nonfederal funding increased-this year by 
nearly 13 percent. 
Total FY2016 research expenditures, which include expenditures from grants and contracts 
and funding appropriated to the South Dakota Agriculture Experiment Station and other institutional 
funds allocated to research, are up by $2.3 million from FY2015. 
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-
enhances undergraduate experience 
Undergraduate research in nursing, applied mathematics and 
cell biology has enriched the academic experiences of three 
graduating seniors, who shared their findings with South Dakota 
legislators at the Student Poster Session in March. 
Nursing student Lauren Shell looked at how the College of 
Nursing can better prepare students to address patients' spiritual 
and emotional needs. She chose an academic-specific project 
because she is interested in one day becoming a nurse-educator. 
Shell identified the need for students to practice what they learn 
in class with regard to assessing a client's spiritual needs. She 
concluded that experiential learning and faculty role-modeling 
would help strengthen this part of the nursing curriculum. In July, 
she will begin work at Mercy Medical Center in Des Moines. 
"We will experience mortality and see hardship in others, but we 
must learn to meet patients where they are," she added. "It's about 
being comfortable with the uncomfortable." 
Mathematics major Nick Stegmeier altered a fluid-flow 
simulation program that was part of assistant mechanical 
engineering professor Jeff Doom's dissertation, making it faster and 
able to handle slower fluid flows than the original version. 
Engineers utilize flow simulations to design anything from pipes to 
jet engines. 
"This project is the perfect mix of physics from an engineering 
standpoint and mathematics;' said Stegmeier, who will begin 
graduate work at SDSU this fall. "It opened up this field to me:' 
Using macrophages from mouse bone marrow and mouse fetal 
livers, biology/microbiology major Carson Eisenbeisz examined the 
proteins that interact when colony-stimulating signaling factor-I, or 
CSF-1, binds to CSF-1 receptors on the cell surface. This signaling 
process controls cellular growth. 
"This experience has given me an appreciation for the things we 
do know about biology, the human body and science:' said 
Eisenbeisz, who will attend medical school in the fall. "It has 
sparked my intellectual curiosity." 
Lauren Shell 
Nick Stegrneier 
Garson Eisenbeisz 
